Welcome to our dedicated page for Pavmed news (Ticker: PAVMZ), a resource for investors and traders seeking the latest updates and insights on Pavmed stock.
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) generates frequent news as a diversified commercial-stage medical technology company active in medical devices, diagnostics, and digital health. This news page aggregates press releases, market announcements, and other coverage related to PAVmed’s common stock and its Series Z warrants trading under the symbol PAVMZ.
Company updates often focus on the performance and milestones of its subsidiaries, particularly Lucid Diagnostics Inc. and Veris Health Inc. Lucid Diagnostics regularly reports on EsoGuard Esophageal DNA Test volumes, related revenue, clinical evidence packages, and developments in commercial coverage and reimbursement. Veris Health news commonly addresses progress on the Veris Cancer Care Platform, pilot programs with cancer centers, financing activities, and advancement of its implantable physiological monitor.
Investors following PAVMZ-related news can also expect announcements on quarterly and annual financial results, non-GAAP performance measures, and business update conference calls and webcasts. PAVmed frequently issues releases detailing business updates for specific quarters, including comments from management on strategy, subsidiary performance, and capital structure.
Regulatory and listing developments are another recurring theme. News items have covered PAVmed’s efforts to regain or maintain compliance with Nasdaq listing standards, including stockholders’ equity and minimum bid price requirements, as well as actions such as debt restructuring and deconsolidation of Lucid Diagnostics.
By monitoring this news feed, readers can track how PAVmed’s medical device, diagnostics, and digital health activities evolve over time, how Lucid Diagnostics and Veris Health contribute to the overall business, and how capital markets and regulatory developments intersect with the PAVM and PAVMZ securities.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
FAQ
What is the current stock price of Pavmed (PAVMZ)?
